A Phase 3 randomized placebo contolled parellel-group multicenter double blined study to evaluate the efficacy and safetyof Telotristat Etiprate

Administered By

Duke Cancer Institute

Awarded By

Lexicon Pharmaceuticals

Contributors

Morse, Michael Aaron Principal Investigator

Start/End

September 1, 2014 - October 27, 2015